Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
A NOVEL COLORECTAL CANCER SUSC...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
A NOVEL COLORECTAL CANCER SUSCEPTIBILITY SNP IN THE EIF3H PROMOTER INFLUENCES PATIENT SURVIVAL AND RESPONSE TO TREATMENT
Detalles Bibliográficos
Autores principales:
Cheadle, J
,
Smith, C
,
Fisher, D
,
Maughan, T
,
Moskvina, V
,
Meade, A
,
West, H
,
Kaplan, R
Formato:
Conference item
Publicado:
2010
Existencias
Descripción
Ejemplares similares
Vista Equipo
Ejemplares similares
A novel colorectal cancer susceptibility SNP in the EIF3F1 promoter influences patient survival and response to treatment
por: Smith, C, et al.
Publicado: (2010)
BRAF and NRAS locus-specific variants have different outcomes on survival to colorectal cancer
por: Summers, MG, et al.
Publicado: (2016)
THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED
por: Maughan, T, et al.
Publicado: (2010)
HIGH THROUGHPUT SOMATIC PROFILING OF THE RAS-RAF-MAP AND PI3K-PTEN-AKT PATHWAYS IN ADVANCED COLORECTAL CANCER AND CORRELATIONS WITH RESPONSE TO CETUXIMAB
por: Smith, C, et al.
Publicado: (2010)
THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
por: Maughan, T, et al.
Publicado: (2010)